Skip to main content
# Title Research Member Research Year
171 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Mayada Fawzy Sedik Farghaly 2018
172 Tri-modalities for bladder cancer in elderly: Trans-urethral resection, hypofractionated radiotherapy and gemcitabine Dr. Adel Gomaa Mohamed Gabr 2018
173 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
Dr. Hanaan Ahmed Mohammed Ahmed 2018
174 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Amen Hamdy Zaki Ali 2018
175 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Ahmed Refaat Abdel Zaher Mubarak 2018
176 Comparative Study between Anthracycline Based Regimen and Taxane Based Regimen in Metastatic
Gastric Cancer
Dr. Ahmed Mubarak Hefni Ismail 2017
177 Comparative Study between Anthracycline Based Regimen and Taxane Based Regimen in Metastatic
Gastric Cancer
Dr. Abeer Elsayed Ali Ibrahim 2017
178 Feasibility of Concurrent Radiotherapy and Paclitaxel-Based Chemotherapy after Conservative Surgery for Breast Cancer Dr. Adel Gomaa Mohamed Gabr 2017
179 ERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy Prof. Ashraf Zeidan Abdalla Ahmed 2016
180 Demographic Characteristics and Clinico-Pathological
Presentation of Breast Cancer Female Patients in South Egypt
Cancer Institute (2005-2012)
Dr. Adel Gomaa Mohamed Gabr 2016